PPA
EWTX icon

Parametric Portfolio Associates’s Edgewise Therapeutics EWTX Stock Holding History

Parametric Portfolio Associates’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,629
Closed -$176K – 3658
2021
Q3 		$176K Buy
+10,629
New +$192K ﹤0.01% 3461

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Parametric Portfolio Associates's EWTX Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of Edgewise Therapeutics (EWTX) in Q4 2021, closing a stake of 10,629 shares — an estimated $176K sold.

Parametric Portfolio Associates first reported a position in EWTX in Q3 2021 and held it in 1 quarter. The position peaked at $176K in Q3 2021. 58 funds tracked by Wall St. Rank hold EWTX as of Q4 2021.

  • Parametric Portfolio Associates reported no remaining Edgewise Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 10,629 Edgewise Therapeutics shares in Q4 2021, an estimated $176K.
  • Parametric Portfolio Associates first reported a position in Edgewise Therapeutics in Q3 2021 and held it in 1 quarter.
  • Parametric Portfolio Associates's Edgewise Therapeutics position peaked at $176K in Q3 2021.
  • 58 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.